en

PRODUCT DETAIL

Mysimba 8 mg/90 mg tablety s predĺženým uvoľňovaním

Code 4082B
MA number EU/1/14/988/001
Product Form: tbl plg 112x8 mg/90 mg (blis.PVC/PCTFE/PVC/Al)
MA Status: E - Valid centralised marketing authorisation
Type of procedure: EU
Therapeutic Class: 08 - ANOREXICA
ATC:
A ALIMENTARY TRACT AND METABOLISM
A08 ANTIOBESITY PREPARATIONS, EXCL. DIET PRODUCTS
A08A ANTIOBESITY PREPARATIONS, EXCL. DIET PRODUCTS
A08AA Centrally acting antiobesity products
A08AA62 Bupropion and naltrexone
Shelf life: 30
Container: blister PVC/PCTFE/PVC/Al
Route of admin.: Oral use
Prescription Status: Medicinal product subject to medical prescription.
Legal basis: Article 10b fixed combination application
MA issued: 26.03.2015
SmPC + PL: European Medicines Agency's database
Safety feature Yes
Data update: 31.01.2020
eu-flag.png sk-flag.png